Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Karyopharm Therapeut

(NASDAQ: KPTI)
Add to Portfolio
-0.59 (-5.21%)
as of Sep 20, 2019

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds

BusinessWire via COMTEX - 10:00AM EDT
Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of all investors that purchased Karyopharm, Inc. (NASDAQ: KPT(full story)
KPTI: 10.73 (-0.59)

KARYOPHARM 72 HOUR DEADLINE ALERT: Former Louisiana

BusinessWire via COMTEX - Fri Sep 20, 10:50PM EDT
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with losses in excess of $100,000 that they have only until September 23, 2019 to file lead plaintiff(full story)
KPTI: 10.73 (-0.59)

INVESTOR ALERT - Karyopharm Therapeutics Inc. (KPTI) -

GlobeNewswire via COMTEX - Fri Sep 20, 03:00PM EDT
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Karyopharm Therapeutics Inc. ("Karyopharm" or "the Company") (NASDAQ: KPTI) and certain of its offic(full story)
KPTI: 10.73 (-0.59)

FINAL SEPT. 23 DEADLINE: GLOBALLY RECOGNIZED ROSEN LAW

GlobeNewswire via COMTEX - Fri Sep 20, 01:00PM EDT
Rosen Law Firm, a global investor rights law firm, reminds Karyopharm Therapeutics Inc. (NASDAQ: KPTI) investors who purchased securities: (i) from March 2, 2017 through February 22, 2019, inclusive (the "Class Period"); (ii) in o(full story)
KPTI: 10.73 (-0.59)

KARYOPHARM DEADLINE ALERT: Faruqi & Faruqi, LLP

Newsfile Corp via COMTEX - Fri Sep 20, 10:33AM EDT
New York, New York--(Newsfile Corp. - September 20, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Karyopharm Therapeutics Inc. (NASDAQ: KPTI) ("Karyopharm" or the "Company") of the Sep(full story)
KPTI: 10.73 (-0.59)